🇺🇸 FDA
Pipeline program

Lorcaserin

HM20003768

Phase 1 small_molecule completed

Quick answer

Lorcaserin for Cocaine Use Disorder is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Cocaine Use Disorder
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials